Ceftolozane/tazobactam activity against drug-resistant Enterobacteriaceae and Pseudomonas aeruginosa causing healthcare-associated infections in the Asia-Pacific region (minus China,Australia and New Zealand): report from an Antimicrobial Surveillance Programme (2013–2015) |
| |
摘 要: |
|
收稿时间: | 10 April 2017 |
本文献已被 ScienceDirect 等数据库收录! |
|